Skip to main content
. 2013 Sep 24;141(3):461–470. doi: 10.1007/s10549-013-2697-5

Table 2.

Early-stage treatment patterns in black and white patients with recurrent disease

Treatment, n (%) Black patients (n = 87) White patients (n = 582)
Neoadjuvant systemic therapy 22 (25.3) 118 (20.3)
Adjuvant systemic therapy 58 (66.7) 439 (75.4)
Neoadjuvant/adjuvant trastuzumab 6 (6.9) 44 (7.6)

Patients diagnosed in stages 0–III only or with missing clinical cancer stage